Copyright
©The Author(s) 2022.
World J Diabetes. Sep 15, 2022; 13(9): 668-682
Published online Sep 15, 2022. doi: 10.4239/wjd.v13.i9.668
Published online Sep 15, 2022. doi: 10.4239/wjd.v13.i9.668
Table 1 Pros and cons of imaging modalities to assess hepatic steatosis
| Modality | Pros | Cons |
| US B-Mode | Lack of ionizing radiation | No panoramic view |
| Less expensive | Operator dependency | |
| Repeatable | Limited accuracy diagnosing mild hepatic steatosis | |
| Fast | Rather qualitative nature | |
| Can be performed at the bedside (no need to transport the patient) | Non simple steatosis/NASH differentiation | |
| Useful also for identification of other pathology such as liver lesions | ||
| QUS | Same as US B-Mode | Not always available |
| Quantitative and semiquantitative fat evaluation (less operator sensitive) | Need to buy newer machines and software | |
| Fibroscan | Quantitative evaluation (less operator sensitive) | Expensive equipment that doesn’t supply imaging evaluation |
| Lack of ionizing radiation | ||
| Fast | ||
| Can be performed at the bedside (no need to transport the patient) | ||
| CT | Fast | Ionizing radiation |
| Panoramic view | Limited accuracy diagnosing mild hepatic steatosis | |
| Volumetric rendering | Non simple steatosis/NASH differentiation | |
| High spatial resolution | ||
| Quantitative density evaluation | ||
| MRI | Highly accurate and reproducible for measuring hepatic fat | Expensive |
| Panoramic view | Examination time | |
| Lack of ionizing radiation | Software not always available | |
| Quantitative fat evaluation | ||
| MRS | Highly accurate and reproducible for measuring hepatic fat | Expensive |
| Panoramic view | Examination time | |
| Lack of ionizing radiation | Software not always available | |
| Quantitative fat evaluation | Evaluation of small portion of the liver | |
| Expertise required for data acquisition and analysis |
- Citation: Bellini MI, Urciuoli I, Del Gaudio G, Polti G, Iannetti G, Gangitano E, Lori E, Lubrano C, Cantisani V, Sorrenti S, D’Andrea V. Nonalcoholic fatty liver disease and diabetes. World J Diabetes 2022; 13(9): 668-682
- URL: https://www.wjgnet.com/1948-9358/full/v13/i9/668.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i9.668
